Vaccine manufacturing company Serum Institute of India on Tuesday said the Oxford University and AstraZeneca’s Covid-19 vaccine will not be released in India for mass use unless proven immunogenic and safe.
Governor Gavin Newsom on Monday tweeted that California will receive 327,000 doses of a Covid-19 vaccine in December, bringing some cheer after his announcement that he might have to again impose stay at home orders because of a surge in coronavirus cases.
iNDICA NEWS BUREAU- When the COVID-19 vaccines are finally out, prioritization of who will get when is one of the most challenging tasks for global leaders, scientists, and decision-makers. To play it safe and sensitive, US President-elect Joe Biden has decided to let health experts make that choice on who will get a vaccine in […]
AstraZeneca announced Monday that positive high-level results from an interim analysis of clinical trials of its Covid-19 vaccine candidate in the UK and Brazil showed it was highly effective
iNDICA NEWS BUREAU- COVID-19 affects our body in various life-threatening ways like inflammation, lung damage, and organ failure. And doctors around the world are still discovering new information about this virus. Now an Indian-American doctor and scientist have discovered a potential strategy to prevent many of these life-threatening situations in patients diagnosed with COVID-19. Dr. […]
The Covid-19 vaccine being developed by British-Swedish pharmaceutical firm AstraZeneca and England’s Oxford University produced a strong immune response in older adults.
iNDICA NEWS BUREAU- Dr. Vivek Murthy’s appointment as a top aide to co-chair President-Elect Joe Biden’s Corona Virus Task Force, comes at a time when the country is deeply divided on various fronts. His appointment has raised hope and optimism across the country that looks forward to an America that is inclusive and committed to […]
iNDICA NEWS BUREAU- American drug major Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories. Pfizer alleges that the two Indian drug makers were planning separately to develop generic versions of its best-selling drug Ibrance (palbociclib) before the expiration of its patent. Pfizer […]